Melbourne event April 3rd, page-38

That photo.

The presence of Christoph Zielinski suggests that the key agenda topic may have been the current Her-Vaxx trial - Zielinski is the principal investigator.

The presence of Axel Hoos along with Paul Hopper, Leslie Chong and Charles Walker gives the meeting the added status of the full Board of Directors.

It was certainly medical and scientific but also possibly strategic with key decisions to be made regarding future development. Best of all, it was made available to shareholders with the simple caption - Imugene meeting in Vienna. The tease may have been that a picture is worth a thousand words.